Will Simpler Devices Tap the Largest Diabetes Market?

The clinical community and the medical device industry are finally turning their attention to the majority of patients with diabetes: the type 2s. They're an underserved group in a potential market that dwarfs that of type 1 diabetes. Health Advances LLC believes that the next disruptive technology in diabetes management will come in the form of lower-cost, easy-to-use insulin pumps for the masses. And there are at least 16 such pumps in development. (See also the sidebar, CeQur: Conforming to the Lifesyle of the Type 2).

Marie Schiller, Andrew Funderburk, Sheela Hegde, and Kathryn Strayer-Benton

For many insulin-requiring patients with type 2 diabetes, disease management is complicated, requiring frequent glucose tests and multiple drug regimens...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip